Barclays »

Kalaris Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $51k 6.1k 8.44
2025-03-31 $0 1 0.00